Health Data Analytics Institute logo
Request demo

Category: Nassib Chamoun

Health Data Analytics Institute (HDAI) deploys innovative use of LLMs for summarizing and supporting patient preferences at a leading cancer center

PR Newswire logo

Distributed by PRNewswire HDAI collaborates with Dana-Farber to help clinicians improve goal-concordant care for patients with serious illness BOSTON, Oct. 20, 2025 /PRNewswire/ — An innovative new protocol called Better Real-time Information on Documentation of Goals of care for Engagement in Serious Illness Communication (BRIDGE-SIC) is being launched today at Dana-Farber Cancer Institute. BRIDGE-SIC uses Health […]

HDAI to announce AI tools that drive quality outcomes at HLTH 2025

PR Newswire logo

Distributed by PRNewswire LAS VEGAS, Oct. 19, 2025 /PRNewswire/ — Nassib Chamoun, CEO of Health Data Analytics Institute (HDAI), a leader in enterprise risk stratification, will be speaking about “Crystal Ball Medicine” at HLTH in Las Vegas this week. At the event, Chamoun, an experienced health tech entrepreneur, will announce the general availability of the first […]

2025 Quality and Safety Conference Points to Bold Future of Surgical Quality

Nassib Chamoun at ACS 2025

During a session on the future of surgery, Nassib Chamoun, founder, president, and CEO of Health Data Analytics Institute addressed current and near-future uses of AI within surgical care workflows. He noted that AI could save a significant amount of clinician time managing patient information in the EHR by proactively designing the right patient workflow, […]

Stefan Weitz, experienced healthcare investor and entrepreneur, joins HDAI board of directors

PR Newswire logo

Distributed by PRNewswire BOSTON, MA, March 20, 2025 – Today, Health Data Analytics Institute (HDAI), a HealthTech company focused on addressing the US’s looming healthcare crisis with actionable, responsible AI tools, announced the appointment of Stefan Weitz to the company’s board of directors. Stefan Weitz, currently CEO and co-founder of HumanX and a veteran of […]

Advanced illness patients

Advanced illness patients video screenshot

Advanced illness patients represent only about 6.5% of the Medicare population yet they drive the majority of cost, utilization, and negative outcomes, specifically about 35% of adverse events, 50% of readmissions, and more than half of inpatient deaths. ​​Predictive models help to identify these specific patients early on in their hospital journey. This enables proactive clinical […]

Readmissions and physician shortage

AI can help address readmissions

Readmissions have become a challenge for many health systems and difficult for patients and their families. AI and predictive analytics play an important role in identifying these patients in real-time before they leave the hospital, enabling proactive, personalized care that can keep them healthy at home and reduce future readmissions. Video by Nassib Chamoun https://vimeo.com/1056025533/2124643300%20 Full […]

Houston Methodist and HDAI speak to the promise of AI for addressing the healthcare crisis at the first annual HumanX conference in Las Vegas 

PR Newswire logo

Distributed by PRNewswire LAS VEGAS, March 9, 2025 /PRNewswire/ — C-suite leaders from Houston Methodist and Health Data Analytics Institute (HDAI) will be speaking at HumanX, discussing how AI can play a pivotal role in addressing the looming hospital capacity crisis and out of control healthcare expenses, while also improving quality and reducing epidemic levels of clinician burnout.  […]

Hospital CEO Advice

Nassib Chamoun gives hospital CEO's advice

What straightforward tactic should clinical and operational leaders consider to make an impact on mortality and readmissions in fairly short order?​ ​Prioritize appointments within 7-14 days of discharge for high-risk patients.​ ​Watch this video as HDAI’s CEO Nassib Chamoun shares an example of how this strategy is working at a major academic medical center. Video […]

Nassib Chamoun’s Big Ideas for 2025

HDAI CEO Nassib Chamoun

In 2025, health systems that use clinical AI applications will begin to move from point solutions to enterprise platforms to demonstrate improvements in these 4 areas: ​ 1) Drive better patient outcomes​ 2) Manage utilization of scarce resources ​ 3) Improve economics​ 4) Make clinicians’ lives easier Video by Nassib Chamoun ​ https://vimeo.com/1044414757/de2fe6fae0?share=copy%20 Full Transcript: In […]

Using AI to Understand and Address Post-Discharge Mortality and Readmissions

Houston Methodist and HDAI webinar video graphics

Experts from Houston Methodist  and Health Data Analytics Institute (HDAI) discuss the challenges and advantages of an AI-driven approach.  When patients leave the hospital, the hope is they won’t return soon; but that’s often not the case. Post-discharge mortality and readmissions can be a crucial metric in financial and reputational value. Organizations have struggled to […]

Raphael Cohen
VP AI and Engineering

With expertise in machine learning, cloud computing, and healthcare, Raphael translates complex technical challenges into practical healthcare solutions. He’s pioneered ML platforms to drive innovations in radiology, pathology, and anesthesia while simultaneously improving operational efficiency and scale. Outside of work, he’s an avid cyclist who regularly participates in the Pan-Mass Challenge, enjoys hiking the White Mountains, and is often found playing guitar. He received a BS in Computer Science and Applied Mathematics from Brandeis University.

Bob Scott
VP Security, Compliance, and IT Operations

Bob has 20 years experience enhancing IT systems and security programs in regulated companies.  He has worked with global enterprises down to 10-person start-ups.  He currently holds both CISSP and CCSP certificates from ISC2.  Bob’s professional passion is negotiating the sweet-spot between Security, Efficiency and Company Resources.  Personally, Bob is a land-locked boatsman who laments every day away from the water and an avid table-top gamer.  He received a BS in Microbiology from Cornell.

Summer Kramer
VP Clinical Programs

Summer is a clinical pharmacist with over 15 years of experience in the healthcare industry, including hospitals, payors, and start-ups. Summer has focused her career on clinical program development and healthcare analytics with a constant drive to improve patient outcomes.

Residing in the pacific northwest, Summer enjoys hiking, camping, sailing, and traveling. She received her PharmD from the University of New Mexico, College of Pharmacy.  

Kevin Sampson
VP Finance

Kevin is a CPA with 25 years of executive and managerial experience in accounting, corporate finance, and operations in a variety of industries including medical device, biotechnology, and pharmaceuticals.

By listening and connecting with people, Kevin understands that accurate timely information is vital for everyone in the healthcare system. He received a BS in Accounting and an MBA in Finance and Entrepreneurial Studies from Babson College.

Paul Manberg
VP Clinical and Regulatory Affairs

Paul is an innovative, pragmatic leader with over 40 years’ experience in the medical device and pharmaceutical industries. He has directed clinical trial programs and regulatory activities supporting the successful market introduction of numerous impactful products. He spends his leisure time on the Outer Banks of North Carolina, body surfing and fishing. He received a PhD in pharmacology from The University of North Carolina School of Medicine.

Scott Greenwald
Chief Scientist

With over 25 years’ experience in healthcare research and innovation, Scott is an unprecedented leader in his field, focusing on improved care for everyone. He is an author of over 10 US Patents and over 100 peer-reviewed abstracts and manuscripts. While he’s not immersed in research, you’ll find him playing a mean round of mini golf. He received a PhD in Medical Engineering from the Harvard-MIT Division of Health Sciences and Technology (HST).

Josh Gray VP Analytic Services

Josh has 30 years’ experience in healthcare, including The Advisory Board Company, athenahealth, and Boston Consulting Group. Across his career, he has used a wide range of conventional and unconventional data sources to understand and teach the keys to top performance among the nation’s most innovative health systems and physician groups. Josh enjoys music, hiking, traveling, and watching his daughter take part in synchronized skating competitions. He received an MBA from The Wharton School at the University of Pennsylvania and an undergraduate degree from Brown University.

Carola Endicott
VP Customer Engagement, Marketing

Carola has 30 years’ experience in healthcare, including HMOs, hospitals, and start-ups. Her knowledge and optimistic outlook in operations and leadership, and her passion for making healthcare workers’ lives easier is what drives her devotion to customer engagement. She received an EdM from Harvard University Graduate School of Education.

David Clain Chief Product Officer

David has vast experience with healthcare customers from his time at The Advisory Board Company and athenahealth. His expertise and passion for statistics, strategy, and innovative analytic insights is unrivaled, as is his devotion to the Duke Blue Devils. Looking for that “aha moment” of positive change is what drives him. He received a BA from Duke University.

Margie Ahearn
VP HR

Margie has 25 years of experience in HR leadership. An avid boater, Margie has received numerous awards for excellence in HR and is always looking for challenges to grow professionally and personally. She graduated with an MBA from Southern New Hampshire University.

Nassib Chamoun
Founder and CEO

Nassib is a data scientist, lover of logistical regression and a serial entrepreneur. Previously, he was Founder and CEO of Aspect Medical Systems, a Nasdaq traded company now owned by Medtronic. Outside of work, he enjoys hosting and honing his cooking skills – specializing in Middle Eastern and outdoor feasts. He received an MS from Boston University.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.

What guides our culture

1

We are driven to make a profound impact on US healthcare

2

We operate in the best interests of patients and those who serve them

3

We understand and protect patient privacy and health information security

4

We use data science to enhance, but never replace clinical expertise and judgment

5

We are committed to continuous learning and improvement

6

We bring rigor, discipline, and reliability to our work

7

We start with kindness, assuming good intent in others

8

We are committed to building a diverse, inclusive team where all employees feel welcomed and appreciated

9

We are committed to the well-being of our employees and their families

Our vision

We envision a healthcare system where decisions are routinely informed by personalized care profiles and predictive analytics, which will improve the health of individuals and populations.

Our mission

Deploy a versatile analytic platform that creates a shared understanding of quantified health risks to inform actions with the greatest potential to benefit patients.

Who we are

We collaborate with leading health systems and integrated delivery networks, value-based care and accountable care organizations, physician groups, and commercial payers to improve care delivery and population health while reducing costs and making efficient use of scarce clinical resources.

Phil Devlin
COO

Phil has 30 years of experience in executive leadership. Along his journey he’s made effective and profound change in science. Little known facts about him — he loves traveling with his family, he was in the MD Engineering program at Harvard Medical School and owns 15 patents. He received an MS from Northeastern University.